DK325289A - Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet - Google Patents

Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet Download PDF

Info

Publication number
DK325289A
DK325289A DK325289A DK325289A DK325289A DK 325289 A DK325289 A DK 325289A DK 325289 A DK325289 A DK 325289A DK 325289 A DK325289 A DK 325289A DK 325289 A DK325289 A DK 325289A
Authority
DK
Denmark
Prior art keywords
salt
preparing
pharmaceutical agents
agents containing
strontium
Prior art date
Application number
DK325289A
Other languages
Danish (da)
English (en)
Other versions
DK325289D0 (da
Inventor
Michel Wierzbicki
Jacqueline Bonnet
Yannis Tsouderos
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of DK325289D0 publication Critical patent/DK325289D0/da
Publication of DK325289A publication Critical patent/DK325289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
DK325289A 1988-06-29 1989-06-29 Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet DK325289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant

Publications (2)

Publication Number Publication Date
DK325289D0 DK325289D0 (da) 1989-06-29
DK325289A true DK325289A (da) 1989-12-30

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK325289A DK325289A (da) 1988-06-29 1989-06-29 Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet

Country Status (16)

Country Link
US (1) US4939164A (zh)
EP (1) EP0349432B1 (zh)
JP (1) JPH0248567A (zh)
AT (1) ATE81118T1 (zh)
AU (1) AU613297B2 (zh)
CA (1) CA1312333C (zh)
DE (1) DE68903059T2 (zh)
DK (1) DK325289A (zh)
ES (1) ES2044170T3 (zh)
FR (1) FR2633619B1 (zh)
GR (1) GR3006674T3 (zh)
IE (1) IE64112B1 (zh)
NZ (1) NZ229760A (zh)
OA (1) OA09121A (zh)
PT (1) PT91006B (zh)
ZA (1) ZA894945B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
AU2004237438B2 (en) * 2003-05-07 2011-01-20 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
CA2519189C (en) * 2003-05-07 2012-07-17 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
EP1732575B1 (en) * 2004-02-26 2010-12-29 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
DK1768748T4 (da) 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
EP3206803A1 (en) 2014-10-14 2017-08-23 Unilever NV Spraying device
US10385560B2 (en) 2014-10-14 2019-08-20 Conopco, Inc. Device for spraying an enclosure triggered by inclination of a rotatable lid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
IE64112B1 (en) 1995-07-12
CA1312333C (fr) 1993-01-05
AU613297B2 (en) 1991-07-25
DK325289D0 (da) 1989-06-29
JPH0248567A (ja) 1990-02-19
JPH0587064B2 (zh) 1993-12-15
FR2633619A1 (fr) 1990-01-05
FR2633619B1 (fr) 1991-02-08
OA09121A (fr) 1991-10-31
PT91006B (pt) 1994-11-30
NZ229760A (en) 1991-06-25
ATE81118T1 (de) 1992-10-15
DE68903059T2 (de) 1993-04-29
EP0349432B1 (fr) 1992-09-30
EP0349432A1 (fr) 1990-01-03
IE892094L (en) 1989-12-29
DE68903059D1 (de) 1992-11-05
US4939164A (en) 1990-07-03
ES2044170T3 (es) 1994-01-01
AU3709289A (en) 1990-01-04
PT91006A (pt) 1989-12-29
ZA894945B (en) 1990-03-28
GR3006674T3 (zh) 1993-06-30

Similar Documents

Publication Publication Date Title
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK90888D0 (da) Maaleapparat til vaevsmetabolisme
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DK393188A (da) Farmaceutisk praeparat til intranasal administrering
DK134990A (da) Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DK561589D0 (da) Flydende oralt farmaceutisk praeparat
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
FI890864A (fi) Anvaendning av 1,4-dihydropyridinderivat.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
IE811612L (en) Thiazoles
NO920524D0 (no) Kynurensyrederivater, deres fremstilling og farmasoeytiskeblandinger inneholdende disse
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
ATE18132T1 (de) Pharmazeutische praeparate zur behandlung von nagelentzuendungen.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
DK492686D0 (da) Vacumtelt til terapeutisk behandling

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment